Mark Kavonian is a distinguished inventor based in North Reading, MA, recognized for his contributions to the field of synthetic membranes. With two patents to his name, he has made significant advancements that have implications for both the pharmaceutical and biomolecular fields.

Latest Patents

Kavonian's latest inventions include:

1. **Polymeric membranes with human skin-like permeability properties and uses thereof** - This patent describes synthetic membranes that serve as substitutes for human skin, allowing for the investigation of transdermal diffusion of pharmaceutical and cosmetic compounds. The membranes demonstrate human skin-like permeability, facilitating the diffusion of a wide array of compounds with varied physico-chemical properties.

2. **Centrifugal filter** - This filtration device is designed for the concentration of liquid samples, particularly biomolecules. The invention features a housing with a sample reservoir and two vertically oriented membranes that enhance filtration efficiency. The setup enables remarkable recoveries of liquid samples, exceeding 90%, and maintains a larger available membrane area during the final stages of filtration compared to traditional single-panel filters.

Career Highlights

Mark Kavonian is currently employed at Emd Millipore Corporation, where he focuses on innovative developments in filtration and membrane technology. His work is pivotal in enhancing processes related to biomolecule purification and pharmaceutical applications.

Collaborations

Throughout his career, Kavonian has collaborated with esteemed colleagues such as Louis L. Bonhomme and John Doyle. These partnerships have contributed to advancing research and fostering innovation in the field of membrane technology.

Conclusion

Mark Kavonian's contributions to synthetic membranes exemplify the impact of innovation in science and technology. His groundbreaking patents not only enhance the understanding of transdermal diffusion but also improve the efficiency of biomolecular filtration. His work continues to pave the way for future advancements in these critical areas.